Antioxidant May Help Lower Blood Pressure
Supplement May Reduce Dependence on Blood Pressure-Lowering Drugs
WebMD News Archive
Feb. 20, 2004 -- Taking an antioxidant supplement made from the bark of French pine trees may help people with high blood pressure reduce their dependence on medications taken to keep their blood pressure under control, new research shows.
The study shows that people with high blood pressure who took the supplement, called Pycnogenol, were able to lower their daily dose of blood pressure-lowering medications by more than 30% while still keeping their blood pressure within normal levels.
Researchers say the supplement contains a high concentration of polyphenols, a type of antioxidant also found in foods such as grapes, and flavonoids, such as those found in green tea. Mounting studies have shown that these plant-based antioxidants may have a number of healthy effects, including lowering cholesterol levels and improving circulation.
By lowering the dependence on blood pressure-lowering drugs with natural antioxidants, researchers say it may be possible to reduce the side effects as well as the cost of treating high blood pressure.
Antioxidant Supplement Helps Lower Blood Pressure
In the study, researchers looked at the effects of daily supplementation with 100 milligrams of Pycongenol or a placebo in a group of 58 adults with high blood pressure who were also treated with a calcium channel blocker, nifedipine (sold commercially as Adalat and Procardia).
All of the participants started with a 20-milligram daily dose of the calcium channel blocker and their dosage was either increased or decreased every two weeks until their blood pressure reached normal levels.
After 12 weeks of treatment, those who received the antioxidant supplement in addition to their medication were able to keep their blood pressure within normal levels with a 15-milligram dose of the drug compared with an average dose of 21.6 milligrams per day among those who took the placebo.
Researchers say the blood pressure-lowering effects of Pycongenol appeared to be caused by the antioxidants effect on the endothelium, the innermost layer of arterial blood vessels that expands and contracts in response to blood flow.
"They produced less of the substances that constrict arteries and more of the substances that dilate [expand] the arteries," says researcher Peter Rohdewald, PhD, retired professor of pharmaceutical chemistry at the University of Münster in Germany. "That recovery of the function of the endothelium is probably the most beneficial effect for the patients."